GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Construction In Progress

Apures Co (XKRX:149300) Construction In Progress : ₩58.2 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Apures Co Construction In Progress?

Apures Co's quarterly construction in progress declined from Dec. 2021 (₩139.1 Mil) to Dec. 2022 (₩58.2 Mil) but then stayed the same from Dec. 2022 (₩58.2 Mil) to Dec. 2023 (₩58.2 Mil).

Apures Co's annual construction in progress declined from Dec. 2021 (₩139.1 Mil) to Dec. 2022 (₩58.2 Mil) but then stayed the same from Dec. 2022 (₩58.2 Mil) to Dec. 2023 (₩58.2 Mil).


Apures Co Construction In Progress Historical Data

The historical data trend for Apures Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co Construction In Progress Chart

Apures Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 264.16 58.16 139.14 58.16 58.16

Apures Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only 264.16 58.16 139.14 58.16 58.16

Apures Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Apures Co (XKRX:149300) Business Description

Traded in Other Exchanges
N/A
Address
44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines